Differential Expression of Wnt Pathway Genes in Sporadic Hepatocellular Carcinomas Infected With Hepatitis B Virus Identified With OligoGE Arrays

Author(s):
Xiaoyan LinXiaoyan Lin1, Qiangxiu WangQiangxiu Wang1, Zhixin CaoZhixin Cao1, Ming GengMing Geng2, Yongcheng CaoYongcheng Cao2, Xiaohong Liu Xiaohong Liu 2,*
1Department of Pathology, Provincial Hospital Affiliated to Shandong University,, China
2Department of Pathology, General Hospital of Jinan Military Command, , China
*Corresponding Author: Department of Pathology, General Hospital of Jinan Military Command, 25 Shifan Road, Jinan 250031, [email protected], China. Tel: +86-53151666857. Fax: +86-53151666284. Email: [email protected]

Hepatitis Monthly:Vol. 13, issue 1; 6192
Published online:Jan 23, 2013
Article type:Research Article
Received:May 10, 2012
Accepted:Jul 28, 2012
How to Cite:Lin X, Wang Q, Cao Z, Geng M, Cao Y, et al. Differential Expression of Wnt Pathway Genes in Sporadic Hepatocellular Carcinomas Infected With Hepatitis B Virus Identified With OligoGE Arrays. Hepat Mon. 2013;13(1):6192. doi: https://doi.org/10.5812/hepatmon.6192

Abstract

Background:

Epidemiological evidence has clearly indicated that chronic infection with the hepatitis B virus (HBV) is the major risk factor for developing hepatocellular carcinoma (HCC). Nonetheless, the mechanisms by which HBV contributes to the pathogenesis of HCC have not been fully elucidated.

Objectives:

Our aim was to characterize differential gene expression profiles related to the Wnt signaling pathway between primary tumor and adjacent normal tissues in HCC patients with concomitant HBVinfection .

Materials and Methods:

An oligoGEArray (an oligonucleotide-based gene expression array platform) containing 126 Wnt signaling pathway-related genes was used to compare gene expressions between primary HCC and adjacent non-tumorous liver tissues from 10 patients with HCC. Selected differential genes were identified with real-time RT-PCR and immunohistochemistry (IHC). In particular, the protein of the differential gene DVL3 (disheveled, dsh homolog 3 [Drosophila]) was chosen to investigate whether it is up regulated in primary tumor correlated with the clinic pathological characteristics of HCC patients. For this purpose we examined 56 HCC tissue samples via IHC for the presence of DVL3 protein.

Results:

Sixteen genes were identified with significant differential expression between HCC and adjacent non-tumorous liver tissue. These genes have been previously associated with the Frizzled signaling pathway, cell cycle, transcription, or protein degradation. All (100%) of the tumor samples results from 56 HCC patients tested were positive for DVL3 via IHC. Based on the intensity of DVL3 immunoreactivity, 25 (44.6%) and 31 (55.4%) of the patients were classified aslow and high-DVL3, respectively, which correlated with tumor stage (P = 0.029).

Conclusions:

This study clarified a number of Wnt pathway-related genes which are dysregulated in HBV-associated HCC. These genes may be contributedto the frequent activation of the Wnt signaling pathway. Our results promote the role of the Wnt signaling pathway in HBV-associated HCC.

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Sep
2020
Hepatitis Monthly

Downregulation of GSK3β and Upregulation of URG7 in Hepatitis B-Related Hepatocellular Carcinoma

Davod Javanmard,
Mohammad Hadi Karbalaie Niya,
Davod Khalafkhany,
Mohammad Najafi,
Masood Ziaee,
Mohammad Reza Babaei
,et al.

Javanmard D, Karbalaie Niya MH, Khalafkhany D, Najafi M, Ziaee M, et al. Downregulation of GSK3β and Upregulation of URG7 in Hepatitis B-Related Hepatocellular Carcinoma. Hepat Mon. 2020;20(8):e100899. doi: https://doi.org/10.5812/hepatmon.100899

1
Jan
2023
Hepat Mon

Comparative Transcriptional Signature Analysis of Peripheral Blood Mononuclear Cells in Early Stage of Hepatitis B-related Hepatocellular Carcinoma

Omid Gholizadeh,
Hossein Bannazadeh Baghi,
Mahin Ahangar Oskouee,
Nader Mohammadzadeh,
Behrooz Naghili,
Narges Eslami
,et al.

Gholizadeh O, Bannazadeh Baghi H, Ahangar Oskouee M, Mohammadzadeh N, Naghili B, et al. Comparative Transcriptional Signature Analysis of Peripheral Blood Mononuclear Cells in Early Stage of Hepatitis B-related Hepatocellular Carcinoma. Hepat Mon. 2022;22(1):e130862. doi: https://doi.org/10.5812/hepatmon-130862

3
Jul
2013

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study

Jamal Sarvari,
Zahra Mojtahedi,
Seyed Ali Reza Taghavi,
Yasuhiro Kuramitsu,
Mahmoud Shamsi Shahrabadi,
Abbas Ghaderi
,et al.

Sarvari J, Mojtahedi Z, Taghavi SAR, Kuramitsu Y, Shamsi Shahrabadi M, et al. Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepat Mon. 2013;13(7):e8351. doi: https://doi.org/10.5812/hepatmon.8351

20
Dec
2025
Hepat Mon

Upregulation of Keratin 19 Expression by Hepatitis B Virus X Protein Promotes Hepatocellular Carcinoma Invasion, Metastasis, and Postoperative Recurrence

Jingyao Shen,
Jie Zhang,
Weimin Sun

Shen J, Zhang J, Sun W. Upregulation of Keratin 19 Expression by Hepatitis B Virus X Protein Promotes Hepatocellular Carcinoma Invasion, Metastasis, and Postoperative Recurrence. Hepat Mon. 2025;25(1):e165724. doi: https://doi.org/10.5812/hepatmon-165724

12
Jan
2019
Vitamin D Receptor <i>Fok I</i> Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients

Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients

Jiawei Rao,
Xukun Wu,
Xiaozhuan Zhou,
Ronghai Deng,
Yi Ma

Rao J, Wu X, Zhou X, Deng R, Ma Y. Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepat Mon. 2019;19(1):e85075. doi: https://doi.org/10.5812/hepatmon.85075

Download PDF536.06 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles